Advanced search×

PET/CT in head and neck cancer: an update.

Roland R Hustinx and Giovanni G Lucignani

Audio, Transactions of the IRE Profession... 37(3):645-51 (2010) PMID 20187296

Version: za2963e q8za6 q8zb0 q8zc1 q8zd3 q8zef q8zfe q8zgb

Similar articles you may find interesting…

  1. PET/CT-guided radiation therapy planning: from present to the future.
    T T Gupta and S S Beriwal

    Audio, Transactions of the IRE Profession... 47(2):126-33 (2010) PMID 20448373

    Molecular imaging using 18F-fluoro-deoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) has been successfully used in the diagnosis, initial staging, and response assessment of various malignant tumors. Advances in radiation therapy planning and delivery have ushered in the era...
  2. Clinical applications of positron emission tomography-computed tomography in oncology.
    R R Kumar, D D Halanaik, and A A Malhotra

    Audio, Transactions of the IRE Profession... 47(2):100-19 (2010) PMID 20448371

    Positron emission computed tomography (PET) is a functional diagnostic imaging technique, which can accurately measure in vivo distribution of a variety of radiopharmaceuticals. The ability of PET to study various biological processes (glucose, amino acid, phospholipids, receptors etc.) opens up new...
  3. Role of positron emission tomography (PET) in head and neck cancer
    M M Duet, F F Hugonnet, and M M Faraggi

    Eur Ann Otorhinolaryngol Head Neck Dis 127(1):6 (2010) PMID 20822756

    F-18 fluorodeoxyglucose positron emission tomography is now part of the initial stage III and IV cancer work-up and each time that metastasis or the presence of a second cancer is suspected that may contraindicate major surgery. Similarly, this exam should be undertaken when the conventional work-up...